At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries. Quality in every detail. From the very start, BIOTRONIK dedicated itself to driving progress and innovation and delivering exceptional quality. We have earned the trust of medical professionals and patients by combining the renowned art of German engineering with technical excellence and uncompromising quality standards. This dedication is evident in everything we do. High achievers are welcome. Medical engineering is an industry of the future. In a field marked by rapid developments and short innovation cycles, the best guarantees for sustainable success are committed, creative, team-oriented specialists, and outstanding leadership. If you are passionate about computer science, engineering or the natural sciences and enjoy developing new ideas, you´ve found the right place. Are you interested? Take a look at our website www.biotronik.com/careers
Externer Link zu BIOTRONIK
Woermannkehre 1
Berlin, 12359, DE
6024 Jean Rd
Lake Oswego, OR 97035, US
BIOTRONIK hat dies direkt geteilt
In a real-world user evaluation, 92% of physicians rated #Oscar as improving procedural efficiency across multiple factors: - Shorter procedural time - Less contrast injection - Fewer device exchanges - Fewer guidewires needed - Reduced fluoroscopy time 👉 Learn more: https://ow.ly/xH4r50U8PS1 #OscarMulti #CLIfighters #PAD #endovascular #VI #WhatWouldYouChoose
BIOTRONIK hat dies direkt geteilt
#InTheNews: read the latest publication in #EuroIntervention on ‘Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicenter registry’ aimed to assess the efficacy and safety of ultrathin strut DES compared to thin-strut DES and drug-eluting balloons (DEB) for DES-ISR. Read the full publication here: https://ow.ly/4Whf50UhuhB #WhatWouldYouChoose #BIOTRONIK #VI #DES #PCI #OrsiroMission
In an exclusive webinar earlier this month, Dr. Larry Chinitz presented the lessons learned from the BIO|CONDUCT trial, focusing on the left bundle branch area pacing (#LBBAP) using a stylet-driven, retractable helix lead. 👉 Haven’t watched it live? Check the video on demand now: https://ow.ly/j4ZQ50UhyH0 #BIOTRONIK #AdvancingCSP
Congratulations! 🌟 Procedures such as Left Bundle Branch Pacing (#LBBAP) open up promising opportunities for patient-centered care. At #BIOTRONIK, we are proud to actively shape the future of cardiology together with dedicated teams through our training programs like the #CSP Preceptorship program.
Sektionsleiter Rhythmologie (Head of rhythmology Department) Facharzt für Innere Medizin und Kardiologie, Zusatzbezeichnung Rhythmologie, aktive Herzrhythmusimplantat, Zusatzbezeichnung Notfallmedizin.
Mit großer Freude wurde vorige Woche ein Patient mit einem relativ neuen Verfahren im Bereich der kardialen Pacing-Therapie behandelt. Es handelt sich dabei um das Left Bundle Branch Pacing (LBBP), eine innovative Methode, die zur Verbesserung der Herzleistung eingesetzt wird. Dieses Verfahren wird erst seit 2–3 Jahren routinemäßig durchgeführt und bietet eine vielversprechende Alternative zu herkömmlichen Schrittmacher-Techniken. Der 74-jährige Patient, der an dilatativer Kardiomyopathie mit hochgradig eingeschränkter systolischer linksventrikulärer Funktion leidet, wurde erfolgreich versorgt. Die Operation verlief komplikationslos, und es konnte eine Reduktion der QRS-Breite um mehr als 60 ms erreicht werden. LBBP stimuliert direkt den linken Tawara-Schenkel und ermöglicht so eine nahezu physiologische Erregungsausbreitung des Herzens. Dies führt zu einer verbesserten Herzfunktion und stabileren elektrischen Aktivierung und ist insbesondere für Patienten mit Herzinsuffizienz oder PM-Indikationen von großem Vorteil. Ohne das engagierte Team wäre eine solche Operation nicht möglich gewesen. Vielen Dank an die Firmen und ärztlichen Kollegen, die bei der Ausbildung unterstützt haben. Boston Scientific Wladislaw Wolf BIOTRONIK Priv.-Doz. Dr. Amr Abdin Dr. Ehssan Berenjkoub. Die Device-Therapie in der Kardiologie am Standort Sulzbach bietet nahezu alle gängigen und modernen Operationsmöglichkeiten im Bereich der Device-Therapie an. Dazu gehören Implantationen von einfachen 1-, 2- und 3-Kammer-Schrittmachern sowie Defibrillatoren (ICD), kabellosen Schrittmachern, S-ICD-Systemen und Conducting System Pacing. Wir sind zukunftsorientiert und stets bemüht, das Beste für unsere Patienten zu leisten. With great pleasure, a patient was successfully treated last week using a relatively new method in the field of cardiac pacing therapy. The procedure involved Left Bundle Branch Pacing (LBBP), an innovative technique designed to improve cardiac performance. This procedure has only been performed routinely for 2–3 years and offers a promising alternative to conventional pacing techniques. The 74-year-old patient, suffering from dilated cardiomyopathy with severely impaired left ventricular systolic function, underwent the procedure without complications. A reduction of more than 60 ms in QRS duration was achieved. LBBP directly stimulates the left bundle branch, ensuring a nearly physiological propagation of electrical impulses in the heart. This leads to improved cardiac function and more stable electrical activation, making it especially beneficial for patients with heart failure or pacing indications. The cardiac device therapy unit at Sulzbach offers nearly all modern procedures in device-based treatments. This includes the implantation of single-, dual-, and triple-chamber pacemakers, ICDs, leadless pacemakers, subcutaneous ICDs (S-ICD), and conducting system pacing. We are future-oriented and committed to providing the best care for our patients.
BIOTRONIK hat dies direkt geteilt
🔬 Exciting Milestone Achieved! 🔬 We are thrilled to announce that the Randomized Controlled Trial (RCT) BIOMAG-II has surpassed 200 enrollments! This significant milestone brings us closer to advancing medical innovation and improving patient care. Learn more about #Freesolve RMS – Metallic performance. Fully resorbable. ➡️ https://ow.ly/XuQi50UgLNz #BIOTRONIK #VI #RMS #Leavenothingbehind #PCI #WhatWouldYouChoose
BIOTRONIK hat dies direkt geteilt
#Freesolve RMS: A new era of resorbable scaffolds: • Delivers like a DES • Optimal vessel support • Resorbed after 12 months • Excellent safety and efficacy What would you choose? 👉 https://ow.ly/2Olu50U7T77 #BIOTRONIK #VI #RMS #WhatWouldYouChoose #leavelessbehind
BIOTRONIK hat dies direkt geteilt
“The improvements that the new #Freesolve device has reached, I think are remarkable” says Dr. Manel Sabate. #Freesolve - Metallic performance. Fully resorbable. #WhatWouldYouChoose 👉 https://ow.ly/1n7v50U7SHb #BIOTRONIK #VI #RMS #leavelessbehind
BIOTRONIK hat dies direkt geteilt
#Oscar: One solution, multiple functions. The Oscar peripheral multifunctional catheter is comprised of a support catheter, an extendable dilator, and a length-adjustable balloon—all in one system. Discover more here: https://ow.ly/oLRB50U8PRR #OscarMulti #CLIfighters #PAD #endovascular #VI #WhatWouldYouChoose
BIOTRONIK UK & Ireland are proud to be raising awareness of sudden cardiac death on behalf of Cardiac Risk in the Young (CRY). Our team members will be doing the "12 A Week Challenge" to complete 12 miles to represent the 12 young people who die each week from young sudden cardiac death. 📣 This year's Raising Awareness Week: From 23rd November to 1st December 2024📣 Sign up here to join in! https://ow.ly/zpmF50Ucx2f #TeamBIOTRONIK #CRY #TestMyHeart #SuddenCardiacDeathAwareness #12AWeek
🌟 Empowering Success in #LBBAP With Exceptional Training! 🌟 Set against the stunning backdrop of the historic Hospital de la Santa Creu i Sant Pau in Barcelona, the Left Bundle Branch Area Pacing (LBBAP) - Physician Expert training brought together world-renowned faculty and over 70 participants from across the globe for a truly collaborative learning experience. The program focused on building confidence and skill through hands-on sessions and practical discussions. The commitment and enthusiasm of everyone involved made this event a standout opportunity for growth and support in the field of LBBAP. A heartfelt thank you to our faculty, Prof. Jan De Pooter, MD, PhD, Dr. Oscar Cano, Dr. Zachary Whinnett and Dr. Jose M Guerra, for sharing their expertise and guidance, and to all participants for their active involvement. Together, we’re strengthening LBBAP knowledge and practice in patient care. 💓 #BIOTRONIK #AdvancingCSP #CSPsystem #CardiacCare